Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AGEing and osteoarthritis: a different perspective.

Nicole Verzijl1, Ruud A Bank, Johan M TeKoppele

  • 1TNO Prevention and Health, CE Leiden, The Netherlands. N.Verzijl@pg.tno.nl

Current Opinion in Rheumatology
|September 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double-Orthogonal Gradient-Based High-Throughput Screening Platform for Studying Cell Response Toward Combined Physicochemical Biomaterial Properties.

Small science·2025
Same author

Matrix metalloproteinases in intestinal fibrosis.

Journal of Crohn's & colitis·2023
Same author

Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery.

Cells·2023
Same author

Verteporfin ameliorates fibrotic aspects of Dupuytren's disease nodular fibroblasts irrespective the activation state of the cells.

Scientific reports·2022
Same author

Macromolecular Crowding as a Tool to Screen Anti-fibrotic Drugs: The Scar-in-a-Jar System Revisited.

Frontiers in medicine·2021
Same author

Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets.

Therapeutic advances in gastroenterology·2020

Age-related accumulation of advanced glycation end products in articular cartilage may explain the increased incidence of osteoarthritis in the elderly. Targeting these products offers a novel therapeutic strategy for osteoarthritis prevention and treatment.

Area of Science:

  • Gerontology
  • Rheumatology
  • Biochemistry

Background:

  • Osteoarthritis is the most common musculoskeletal disease in the elderly, with age being the primary risk factor.
  • A clear mechanism linking age to osteoarthritis development remains unidentified, hindering the development of disease-modifying treatments.
  • The increasing elderly population worldwide will exacerbate the socioeconomic burden of osteoarthritis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the age-related increase in osteoarthritis incidence.
  • To identify potential novel therapeutic targets for osteoarthritis.
  • To explore the role of advanced glycation end products in age-related cartilage changes.

Main Methods:

  • Review of existing literature on osteoarthritis, aging, and advanced glycation end products.

Related Experiment Videos

  • Analysis of biochemical and biomechanical changes in articular cartilage associated with aging.
  • Correlation of advanced glycation end product accumulation with cartilage properties and osteoarthritis risk.

    • Main Results:

    • Advanced glycation end products accumulate in human articular cartilage with age.
    • Accumulation of these products alters cartilage biomechanical properties, increasing stiffness and brittleness.
    • Elevated advanced glycation end product concentrations correlate with increased susceptibility to cartilage damage and osteoarthritis.

    Conclusions:

    • Age-related accumulation of advanced glycation end products in articular cartilage provides a potential molecular mechanism for increased osteoarthritis incidence.
    • Inhibiting or reversing advanced glycation end product accumulation presents a promising therapeutic strategy for osteoarthritis.
    • This finding opens new avenues for preventing and treating osteoarthritis by targeting age-related molecular changes.